Devyser’s Prenatal Chromosome Test Gets IVDR Certification
Devyser Compact is a rapid genetic test for prenatal chromosome testing and is approved under the new more comprehensive regulation.
Devyser Compact is a rapid genetic test for prenatal chromosome testing and is approved under the new more comprehensive regulation.
Veritas has created a new prenatal diagnostic test that can help identify fetal anomalies in at-risk pregnancies.
Offering insurance coverage of non-invasive prenatal testing to all pregnant women increases utlilization at a cost of less than 3 cents per member per month.
The Amplify process increases the fetal fraction of a NIPS sample by preferentially sequencing the fetal cell-free DNA fragments that circulate in a mother’s blood.
Read MoreThe discovery of two novel biomarkers—FKBPL and CD44—has the potential to change the way preeclampsia is managed.
Read MoreThe new funding will be used to support commercial expansion of the company’s Unity prenatal screening test to all US states as well as research and development for future diagnostics.
Read MoreThermo Fisher and NX Prenatal will develop clinical mass spectrometry-based workflows for monitoring maternal and fetal health during pregnancy, and evaluating the risk of complications.
Read MoreThe test broadens expectant parents’ prenatal testing options to include a safe, noninvasive test tailored to their family’s risk for a specific genetic disease.
Read MoreThe Foresight carrier screen identified 45% more couples at risk for having a child with cystic fibrosis than current guideline-based testing.
Read MoreA novel multiplexing platform called ‘high definition polymerase chain reaction’ brings together widely used, low-cost chemistries and qPCR instrumentation with proprietary data science algorithms to enable streamlined multiplex test development and very affordable test deliverables.
Read MoreThe Parsortix system offers the potential to extend NIPT to a wide range of conditions not feasible with existing techniques.
Read MoreStatisticians used data from more than a million Panorama tests to devise an algorithm that computes a fetal fraction-based risk score for pregnancy.
Read MoreThis month’s Product News section features products from Qiagen, ELITechGroup Biomedical Systems, and DiaSorin Molecular.
Read MoreA noninvasive prenatal test for zygosity in twin pregnancies enables obstetricians to triage patients and avoid both overtreatment and undertreatment.
Read MoreFor use on Qiagen’s next-generation sequencing system, the cell-free DNA assays will enable access to genetic testing, including prenatal screening, in hospitals and laboratories globally.
Read MoreIllumina has signed a contract with Harvard Pilgrim Health Care to accelerate patient access to next-generation sequencing for noninvasive prenatal testing.
Read MoreThe plastic blood collection tube incorporates a proprietary sample stabilization additive and BD Vacutainer Hemogard technology, and was designed to ensure accurate and reproducible results in molecular diagnostic testing applications using circulating cell-free DNA.
Read MoreThe Panorama noninvasive prenatal test is now validated to screen twin pregnancies for zygosity and chromosomal abnormalities.
Read More